Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin

Gastroenterol Hepatol. 2022 Mar;45(3):177-185. doi: 10.1016/j.gastrohep.2021.03.017. Epub 2021 May 27.
[Article in English, Spanish]

Abstract

Background and aims: Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease that typically affects middle-aged men with ulcerative colitis (UC). However, recent studies point out to epidemiological changes. Our aim was to determine if the epidemiology, clinical course and outcome of patients with PSC followed at a reference hepatology center resemble what is described in the literature.

Patients and method: Retrospective search of patients with a diagnosis of PSC treated in our center between 2000 and 2019.

Results: Cohort of 55 patients (mean age: 37 years), 44% women. Most were large duct type (79%). Most diagnoses were made after 2011. At time of diagnosis, 63% of patients were asymptomatic. The median time from suspicion to diagnosis was 2 years. After a mean follow-up time of 7 years, one third developed cirrhosis, and 25% required liver transplantation (LT); among these, the disease recurred in almost half. Inflammatory bowel disease (IBD) was present in 45%, especially UC. Although statistical significance was not reached, PSC in women was characterized by higher rate of asymptomatic presentation and more frequent association with UC versus other forms of IBD. Women also had more frequently cirrhosis at diagnosis and required LT more often than men.

Conclusion: The epidemiology of PSC is changing. The number of women affected is greater than what was expected from the literature, with a recent increase in incidence. There seems to be differences between sexes in the form of presentation and disease course that should be confirmed in subsequent studies.

Keywords: Colangitis esclerosante primaria; Enfermedad inflamatoria intestinal; Inflammatory bowel disease; Liver transplantation; Primary sclerosing cholangitis; Sex; Sexo; Trasplante hepático.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Antineutrophil Cytoplasmic / blood
  • Antibodies, Antinuclear / blood
  • Asymptomatic Diseases
  • Child
  • Cholangitis, Sclerosing* / complications
  • Cholangitis, Sclerosing* / diagnosis
  • Cholangitis, Sclerosing* / epidemiology
  • Cholangitis, Sclerosing* / surgery
  • Cohort Studies
  • Colitis, Ulcerative / epidemiology
  • Crohn Disease / epidemiology
  • Disease Progression
  • Female
  • Humans
  • Liver Cirrhosis / epidemiology
  • Liver Cirrhosis / surgery
  • Liver Transplantation / statistics & numerical data
  • Male
  • Middle Aged
  • Muscle, Smooth / immunology
  • Recurrence
  • Retrospective Studies
  • Sex Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Antinuclear